{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:51Z","timestamp":1791191811617,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.chroma.2016.03.076","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T01:08:32Z","timestamp":1459559312000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography\u2013tandem mass spectrometry"],"prefix":"10.1016","volume":"1446","author":[{"given":"Madeleine J.","family":"Swortwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl B.","family":"Scheidweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7780-3504","authenticated-orcid":false,"given":"Allan J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2016.03.076_bib0005","unstructured":"J.K. Sarra, L. Hedden, Rachel Lipari, Grace Medley, Peter Tice, Elizabeth A.P. Copello, Larry A. Kroutil, Substance Abuse and Mental Health Services Administration (SAMHSA)."},{"key":"10.1016\/j.chroma.2016.03.076_bib0010","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.chroma.2016.03.076_bib0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/j.semperi.2015.08.013","article-title":"Opioids in pregnancy and neonatal abstinence syndrome","volume":"39","author":"Stover","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.chroma.2016.03.076_bib0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J. Addict. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.chroma.2016.03.076_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.chroma.2016.03.076_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00194-0","article-title":"Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes","volume":"63","author":"Johnson","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.chroma.2016.03.076_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/bfm.2009.9987","article-title":"ABM clinical protocol #21: guidelines for breastfeeding and the drug-dependent woman","volume":"4","author":"Jansson","year":"2009","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.chroma.2016.03.076_bib0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.ftd.0000164612.83932.be","article-title":"Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography\u2013tandem mass spectrometry","volume":"27","author":"Grimm","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.chroma.2016.03.076_bib0045","first-page":"125","article-title":"Case study of neonates born to mothers undergoing buprenorphine maintenance treatment","author":"Marquet","year":"2002","journal-title":"Buprenorphine Ther. Opiate Addict."},{"key":"10.1016\/j.chroma.2016.03.076_bib0050","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.chroma.2016.03.076_bib0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jps.2600740505","article-title":"Pharmacokinetics of morphine and its surrogates VI: bioanalysis, solvolysis kinetics, solubility, pK' values, and protein binding of buprenorphine","volume":"74","author":"Garrett","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2016.03.076_bib0060","first-page":"818","article-title":"Human buprenorphine n-dealkylation is catalyzed by cytochrome P450 3A4","volume":"26","author":"Kobayashi","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chroma.2016.03.076_bib0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0090-9556(25)07765-7","article-title":"The metabolism and excretion of buprenorphine in humans","volume":"12","author":"Cone","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chroma.2016.03.076_bib0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0b013e318228bb2a","article-title":"Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women","volume":"33","author":"Concheiro","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.chroma.2016.03.076_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jat\/33.8.409","article-title":"Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"33","author":"Fang","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.chroma.2016.03.076_bib0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.ftd.0000197094.92559.b4","article-title":"The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"28","author":"Huang","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.chroma.2016.03.076_bib0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchromb.2009.11.005","article-title":"Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women","volume":"878","author":"Concheiro","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2016.03.076_bib0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/bfm.2011.0096","article-title":"Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment","volume":"7","author":"Ilett","year":"2012","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.chroma.2016.03.076_bib0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bmc.1666","article-title":"Development and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography\u2013mass spectrometry","volume":"26","author":"Nikolaou","year":"2012","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.chroma.2016.03.076_bib0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/31.7.394","article-title":"Method for quantification of opioids and their metabolites in autopsy blood by liquid chromatography\u2013tandem mass spectrometry","volume":"31","author":"Al-Asmari","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.chroma.2016.03.076_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/abio.2002.5673","article-title":"A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant naloxone, that is suitable for in vivo and in vitro metabolism studies","volume":"306","author":"Moody","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2016.03.076_bib0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10337-011-2095-2","article-title":"Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by LC-MS-MS","volume":"74","author":"Chiang","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.chroma.2016.03.076_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchromb.2014.01.029","article-title":"Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography\u2013tandem mass spectrometry for the simultaneous determination of naloxone buprenorphine and norbuprenorphine in human plasma","volume":"951\u2013952","author":"Sun","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2016.03.076_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology SWGTOX)","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.chroma.2016.03.076_bib0125","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2016.03.076_bib0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0731-7085(03)00169-9","article-title":"Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry","volume":"32","author":"Ceccato","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2016.03.076_bib0135","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jchromb.2006.11.025","article-title":"Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography\/mass spectrometry","volume":"850","author":"Rodriguez-Rosas","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2016.03.076_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jms.776","article-title":"Liquid chromatographic\/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma","volume":"40","author":"Murphy","year":"2005","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2016.03.076_bib0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0378-4347(01)00029-9","article-title":"Simultaneous determination of buprenorphine, norburpennorphine, and buprenorphine-glucuronide in plasma by liquid charmatography-tandem mass spectrometry","volume":"754","author":"Polettini","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967316303922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967316303922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:43:13Z","timestamp":1758260593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967316303922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":29,"alternative-id":["S0021967316303922"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2016.03.076","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography\u2013tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2016.03.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}